{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:15:14Z","timestamp":1780352114131,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T00:00:00Z","timestamp":1628035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Functional Respiratory Imaging (FRI) combines HRCT scans with computational fluid dynamics to provide objective and quantitative information about lung structure and function. FRI has proven its value in pulmonary diseases such as COPD and asthma, but limited studies have focused on cystic fibrosis (CF). This study aims to investigate the relation of multiple FRI parameters to validated imaging parameters and classical respiratory outcomes in a CF population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CF patients aged\u2009&gt;\u20095\u00a0years scheduled for a chest CT were recruited in a cross-sectional study. FRI outcomes included regional airway volume, airway wall volume, airway resistance, lobar volume, air trapping and pulmonary blood distribution. Besides FRI, CT scans were independently evaluated by 2 readers using the CF-CT score. Spirometry and the 6-Minute Walk Test (6MWT) were also performed. Statistical tests included linear mixed-effects models, repeated measures correlations, Pearson and Spearman correlations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>39 CT scans of 24 (17M\/7F) subjects were analyzed. Patients were 24\u2009\u00b1\u20099\u00a0years old and had a ppFEV<jats:sub>1<\/jats:sub> of 71\u2009\u00b1\u200925% at the time of the first CT. All FRI parameters showed significant low-to-moderate correlations with the total CF-CT score, except for lobar volume. When considering the relation between FRI parameters and similar CF-CT subscores, significant correlations were found between parameters related to airway volume, air trapping and airway wall thickening. Air trapping, lobar volume after normal expiration and pulmonary blood distribution showed significant associations with all spirometric parameters and oxygen saturation at the end of 6MWT. In addition, air trapping was the only parameter related to the distance covered during 6MWT. A subgroup analysis showed considerably higher correlations in patients with mild lung disease (ppFEV<jats:sub>1<\/jats:sub>\u2009\u2265\u200970%) compared to patients with moderate to severe lung disease (ppFEV<jats:sub>1<\/jats:sub>\u2009&lt;\u200970%) when comparing FRI to CF-CT scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Multiple structural characteristics determined by FRI were associated with abnormalities determined by CF-CT score. Air trapping and pulmonary blood distribution appeared to be the most clinically relevant FRI parameters for CF patients due to their associations with classical outcome measures. The FRI methodology could particularly be of interest for patients with mild lung disease, although this should be confirmed in future research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-021-01622-3","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:02:52Z","timestamp":1628060572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Functional respiratory imaging in relation to classical outcome measures in cystic fibrosis: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-0206","authenticated-orcid":false,"given":"Eline","family":"Lauwers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Snoeckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Ides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Van Hoorenbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Lanclus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"1622_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/1025448x.erm6414","author":"MA Mall","year":"2014","unstructured":"Mall MA, Elborn JS. Cystic fibrosis. Eur Respir Soc. 2014. https:\/\/doi.org\/10.1183\/1025448x.erm6414.","journal-title":"Eur Respir Soc"},{"key":"1622_CR2","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s00247-014-2964-6","volume":"44","author":"HAWM Tiddens","year":"2014","unstructured":"Tiddens HAWM, Rosenow T. What did we learn from two decades of chest computed tomography in cystic fibrosis? Pediatr Radiol. 2014;44:1490\u20135. https:\/\/doi.org\/10.1007\/s00247-014-2964-6.","journal-title":"Pediatr Radiol"},{"key":"1622_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/thoraxjnl-2011-200912","volume":"67","author":"LS Mott","year":"2012","unstructured":"Mott LS, Park J, Murray CP, Gangell CL, de Klerk NH, Robinson PJ, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 2012;67:509\u201316. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200912.","journal-title":"Thorax"},{"key":"1622_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcf.2019.08.005","volume":"19","author":"CF Bortoluzzi","year":"2020","unstructured":"Bortoluzzi CF, Pontello E, Pintani E, de Winter-de Groot KM, D\u2019Orazio C, Assael BM, et al. The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease. J Cyst Fibros. 2020;19:641\u20136. https:\/\/doi.org\/10.1016\/j.jcf.2019.08.005.","journal-title":"J Cyst Fibros"},{"key":"1622_CR5","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1148\/radiology.179.3.2027992","volume":"179","author":"M Bhalla","year":"1991","unstructured":"Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179:783\u20138. https:\/\/doi.org\/10.1148\/radiology.179.3.2027992.","journal-title":"Radiology"},{"key":"1622_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.rti.0000203937.82276.ce","volume":"21","author":"AS Brody","year":"2006","unstructured":"Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging. 2006;21:14\u201321. https:\/\/doi.org\/10.1097\/01.rti.0000203937.82276.ce.","journal-title":"J Thorac Imaging"},{"key":"1622_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2011.954","volume":"306","author":"CE Wainwright","year":"2011","unstructured":"Wainwright CE, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, et al. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA J Am Med Assoc. 2011;306:163\u201371. https:\/\/doi.org\/10.1001\/jama.2011.954.","journal-title":"JAMA J Am Med Assoc"},{"key":"1622_CR8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1164\/rccm.201501-0061OC","volume":"191","author":"T Rosenow","year":"2015","unstructured":"Rosenow T, Oudraad MCJ, Murray CP, Turkovic L, Kuo W, de Bruijne M, et al. PRAGMA-CF. A quantitative structural lung disease computed tomography outcome in young children with cystic fibrosis. Am J Respir Crit Care Med. 2015;191:1158\u201365. https:\/\/doi.org\/10.1164\/rccm.201501-0061OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1622_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jcf.2016.12.008","volume":"16","author":"R Szczesniak","year":"2017","unstructured":"Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HAWM. Chest imaging in cystic fibrosis studies: what counts, and can be counted? J Cyst Fibros. 2017;16:175\u201385. https:\/\/doi.org\/10.1016\/j.jcf.2016.12.008.","journal-title":"J Cyst Fibros"},{"key":"1622_CR10","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1007\/s00247-013-2867-y","volume":"44","author":"AD Calder","year":"2014","unstructured":"Calder AD, Bush A, Brody AS, Owens CM. Scoring of chest CT in children with cystic fibrosis: state of the art. Pediatr Radiol. 2014;44:1496\u2013506. https:\/\/doi.org\/10.1007\/s00247-013-2867-y.","journal-title":"Pediatr Radiol"},{"key":"1622_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1148\/radiol.2312021393","volume":"231","author":"PA de Jong","year":"2004","unstructured":"de Jong PA, Ottink MD, Robben SGF, Lequin MH, Hop WCJ, Hendriks JJE, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology. 2004;231:434\u20139. https:\/\/doi.org\/10.1148\/radiol.2312021393.","journal-title":"Radiology"},{"key":"1622_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.05.005","author":"SM Stick","year":"2009","unstructured":"Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr. 2009. https:\/\/doi.org\/10.1016\/j.jpeds.2009.05.005.","journal-title":"J Pediatr"},{"key":"1622_CR13","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1007\/s00330-018-5516-x","volume":"28","author":"G Chassagnon","year":"2018","unstructured":"Chassagnon G, Martin C, Burgel PR, Hubert D, Fajac I, Paragios N, et al. An automated computed tomography score for the cystic fibrosis lung. Eur Radiol. 2018;28:5111\u201320. https:\/\/doi.org\/10.1007\/s00330-018-5516-x.","journal-title":"Eur Radiol"},{"key":"1622_CR14","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ppul.23787","volume":"52","author":"W Kuo","year":"2017","unstructured":"Kuo W, Soffers T, Andrinopoulou E-R, Rosenow T, Ranganathan S, Turkovic L, et al. Quantitative assessment of airway dimensions in young children with cystic fibrosis lung disease using chest computed tomography. Pediatr Pulmonol. 2017;52:1414\u201323. https:\/\/doi.org\/10.1002\/ppul.23787.","journal-title":"Pediatr Pulmonol"},{"key":"1622_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.13-0588","volume":"145","author":"EM DeBoer","year":"2014","unstructured":"DeBoer EM, Swiercz W, Heltshe SL, Anthony MM, Szefler P, Klein R, et al. Automated CT scan scores of bronchiectasis and air trapping in cystic fibrosis. Chest. 2014;145:593\u2013603. https:\/\/doi.org\/10.1378\/chest.13-0588.","journal-title":"Chest"},{"key":"1622_CR16","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.ejrad.2015.02.011","volume":"84","author":"M Loeve","year":"2015","unstructured":"Loeve M, Rosenow T, Gorbunova V, Hop WCJ, Tiddens HAWM, de Bruijne M. Reversibility of trapped air on chest computed tomography in cystic fibrosis patients. Eur J Radiol. 2015;84:1184\u201390. https:\/\/doi.org\/10.1016\/j.ejrad.2015.02.011.","journal-title":"Eur J Radiol"},{"key":"1622_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jcf.2019.09.001","volume":"19","author":"M van Straten","year":"2020","unstructured":"van Straten M, Brody AS, Ernst C, Guillerman RP, Tiddens HAWM, Nagle SK. Guidance for computed tomography (CT) imaging of the lungs for patients with cystic fibrosis (CF) in research studies. J Cyst Fibros. 2020;19:176\u201383. https:\/\/doi.org\/10.1016\/j.jcf.2019.09.001.","journal-title":"J Cyst Fibros"},{"key":"1622_CR18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100322\/-\/DC1","author":"JW de Backer","year":"2010","unstructured":"de Backer JW, Vos W, Vinchurkar S, Claes R, Drollmann A, Wulfrank D, et al. Validation of computational fluid dynamics in CT-based AIRWAY MODELS with SPECT\/CT1. Radiology. 2010. https:\/\/doi.org\/10.1148\/radiol.10100322\/-\/DC1.","journal-title":"Radiology"},{"key":"1622_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.medengphy.2007.11.002","volume":"30","author":"JW de Backer","year":"2008","unstructured":"de Backer JW, Vos WG, Gorl\u00e9 CD, Germonpr\u00e9 P, Partoens B, Wuyts FL, et al. Flow analyses in the lower airways: patient-specific model and boundary conditions. Med Eng Phys. 2008;30:872\u20139. https:\/\/doi.org\/10.1016\/j.medengphy.2007.11.002.","journal-title":"Med Eng Phys"},{"key":"1622_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/1753466620916990","author":"W de Backer","year":"2020","unstructured":"de Backer W, de Backer J, Verlinden I, Leemans G, van Holsbeke C, Mignot B, et al. Functional respiratory imaging assessment of glycopyrrolate and formoterol fumarate metered dose inhalers formulated using co-suspension delivery technology in patients with COPD. Ther Adv Respir Dis. 2020. https:\/\/doi.org\/10.1177\/1753466620916990.","journal-title":"Ther Adv Respir Dis"},{"key":"1622_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/17476348.2016.1192464","volume":"10","author":"J de Backer","year":"2016","unstructured":"de Backer J, van Holsbeke C, Vos W, Vinchurkar S, Dorinsky P, Rebello J, et al. Assessment of lung deposition and analysis of the effect of fluticasone\/salmeterol hydrofluoroalkane (HFA) pressurized metered dose inhaler (pMDI) in stable persistent asthma patients using functional respiratory imaging. Expert Rev Respir Med. 2016;10:927\u201333. https:\/\/doi.org\/10.1080\/17476348.2016.1192464.","journal-title":"Expert Rev Respir Med"},{"key":"1622_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1148\/radiol.2015142278","volume":"278","author":"BA Tahir","year":"2016","unstructured":"Tahir BA, van Holsbeke C, Ireland RH, Swift AJ, Horn FC, Marshall H, et al. Comparison of CT-based lobar ventilation with 3He MR imaging ventilation measurements. Radiology. 2016;278:585\u201392. https:\/\/doi.org\/10.1148\/radiol.2015142278.","journal-title":"Radiology"},{"key":"1622_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000347120","volume":"86","author":"W Vos","year":"2013","unstructured":"Vos W, de Backer J, Poli G, de Volder A, Ghys L, van Holsbeke C, et al. Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone\/formoterol. Respiration. 2013;86:393\u2013401. https:\/\/doi.org\/10.1159\/000347120.","journal-title":"Respiration"},{"key":"1622_CR24","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2147\/COPD.S171707","volume":"13","author":"W de Backer","year":"2018","unstructured":"de Backer W, de Backer J, Vos W, Verlinden I, van Holsbeke C, Clukers J, et al. A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate\/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD. Int J COPD. 2018;13:2673\u201384. https:\/\/doi.org\/10.2147\/COPD.S171707.","journal-title":"Int J COPD"},{"key":"1622_CR25","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.2147\/COPD.S136412","volume":"12","author":"B Hajian","year":"2017","unstructured":"Hajian B, de Backer J, Sneyers C, Ferreira F, Barboza KC, Leemans G, et al. Pathophysiological mechanism of long-term noninvasive ventilation in stable hypercapnic patients with COPD using functional respiratory imaging. Int J COPD. 2017;12:2197\u2013205. https:\/\/doi.org\/10.2147\/COPD.S136412.","journal-title":"Int J COPD"},{"key":"1622_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/jamp.2013.1064","volume":"28","author":"J de Backer","year":"2015","unstructured":"de Backer J, Vos W, Vinchurkar S, van Holsbeke C, Poli G, Claes R, et al. The effects of extrafine beclometasone\/formoterol (BDP\/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging. J Aerosol Med Pulm Drug Deliv. 2015;28:88\u201399. https:\/\/doi.org\/10.1089\/jamp.2013.1064.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"1622_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2147\/COPD.S21917","volume":"6","author":"LA de Backer","year":"2011","unstructured":"de Backer LA, Vos WG, Salgado R, de Backer JW, Devolder A, Verhulst SL, et al. Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD. Int J COPD. 2011;6:637\u201346. https:\/\/doi.org\/10.2147\/COPD.S21917.","journal-title":"Int J COPD"},{"key":"1622_CR28","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/ppul.24784","volume":"55","author":"G Leemans","year":"2020","unstructured":"Leemans G, Belmans D, van Holsbeke C, Becker B, Vissers D, Ides K, et al. The effectiveness of a mobile high-frequency chest wall oscillation (HFCWO) device for airway clearance. Pediatr Pulmonol. 2020;55:1984\u201392. https:\/\/doi.org\/10.1002\/ppul.24784.","journal-title":"Pediatr Pulmonol"},{"key":"1622_CR29","doi-asserted-by":"publisher","unstructured":"Lauwers E, Belmans D, Mignot B, Ides K, van Hoorenbeeck K, van Holsbeke C, et al. Functional respiratory imaging to assess the short-term effects of Orkambi (lumacaftor\/ivacaftor) on lung function in patients with cystic fibrosis homozygous for F508del. In: ATS 2020 international conference American thoracic society international conference meetings abstracts. American Thoracic Society; 2020, p. A7910\u2013A7910. https:\/\/doi.org\/10.1164\/ajrccm-conference.2020.201.1_meetingabstracts.a7910.","DOI":"10.1164\/ajrccm-conference.2020.201.1_meetingabstracts.a7910"},{"key":"1622_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338. https:\/\/doi.org\/10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"key":"1622_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/rccm.166\/1\/111","volume":"166","author":"ATS Statement","year":"2002","unstructured":"Statement ATS. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111\u20137. https:\/\/doi.org\/10.1164\/rccm.166\/1\/111.","journal-title":"Am J Respir Crit Care Med"},{"key":"1622_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.rmed.2018.02.016","volume":"137","author":"C Andrade Lima","year":"2018","unstructured":"Andrade Lima C, de Andrade AD, Campos SL, Brand\u00e3o DC, Mourato IP, de Britto MCA. Six-minute walk test as a determinant of the functional capacity of children and adolescents with cystic fibrosis: a systematic review. Respir Med. 2018;137:83\u20138. https:\/\/doi.org\/10.1016\/j.rmed.2018.02.016.","journal-title":"Respir Med"},{"key":"1622_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpeds.2016.11.071","volume":"182","author":"MVF Donadio","year":"2017","unstructured":"Donadio MVF, Heinzmann-Filho JP, Vendrusculo FM, Frasson PXH, Marostica PJC. Six-minute walk test results predict risk of hospitalization for youths with cystic fibrosis: a 5-year follow-up study. J Pediatr. 2017;182:204-209.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.11.071.","journal-title":"J Pediatr"},{"key":"1622_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2019.1663947","author":"I L\u00f3pez-de-Uralde-Villanueva","year":"2019","unstructured":"L\u00f3pez-de-Uralde-Villanueva I, Sarr\u00eda Visa T, Moscard\u00f3 Marichalar P, del Corral T. Minimal detectable change in six-minute walk test in children and adolescents with cystic fibrosis. Disabil Rehabil. 2019. https:\/\/doi.org\/10.1080\/09638288.2019.1663947.","journal-title":"Disabil Rehabil"},{"key":"1622_CR35","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.acra.2020.07.019","volume":"27","author":"M Lins","year":"2020","unstructured":"Lins M, Vandevenne J, Thillai M, Lavon BR, Lanclus M, Bonte S, et al. Assessment of small pulmonary blood vessels in COVID-19 patients using HRCT. Acad Radiol. 2020;27:1449\u201355. https:\/\/doi.org\/10.1016\/j.acra.2020.07.019.","journal-title":"Acad Radiol"},{"key":"1622_CR36","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100322\/-\/DC1","author":"JW de Backer","year":"2010","unstructured":"de Backer JW, Vos WG, Vinchurkar SC, Claes R, Drollmann A, Wulfrank D, et al. Validation of computational fluid dynamics in CT-based airway models with SPECT\/CT. Radiology. 2010. https:\/\/doi.org\/10.1148\/radiol.10100322\/-\/DC1.","journal-title":"Radiology"},{"key":"1622_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155\u201363. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012.","journal-title":"J Chiropr Med"},{"key":"1622_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.00456","author":"JZ Bakdash","year":"2017","unstructured":"Bakdash JZ, Marusich LR. Repeated measures correlation. Front Psychol. 2017. https:\/\/doi.org\/10.3389\/fpsyg.2017.00456.","journal-title":"Front Psychol"},{"key":"1622_CR39","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00748-2019","author":"L Turkovic","year":"2020","unstructured":"Turkovic L, Caudri D, Rosenow T, Breuer O, Murray C, Tiddens HAWM, et al. Structural determinants of long-term functional outcomes in young children with cystic fibrosis. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.00748-2019.","journal-title":"Eur Respir J"},{"key":"1622_CR40","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1378\/chest.128.4.2327","volume":"128","author":"TE Robinson","year":"2005","unstructured":"Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, et al. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest. 2005;128:2327\u201335. https:\/\/doi.org\/10.1378\/chest.128.4.2327.","journal-title":"Chest"},{"key":"1622_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1164\/rccm.200901-0069OC","volume":"180","author":"PD Sly","year":"2009","unstructured":"Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med. 2009;180:146\u201352. https:\/\/doi.org\/10.1164\/rccm.200901-0069OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1622_CR42","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S2213-2600(16)30105-9","volume":"4","author":"JM Wells","year":"2016","unstructured":"Wells JM, Farris RF, Gosdin TA, Dransfield MT, Wood ME, Bell SC, et al. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study. Lancet Respir Med. 2016;4:636\u201345. https:\/\/doi.org\/10.1016\/S2213-2600(16)30105-9.","journal-title":"Lancet Respir Med"},{"key":"1622_CR43","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1164\/rccm.201311-2099CI","volume":"189","author":"W Kuo","year":"2014","unstructured":"Kuo W, Ciet P, Tiddens HAWM, Zhang W, Guillerman RP, van Straten M. Monitoring cystic fibrosis lung disease by computed tomography: radiation risk in perspective. Am J Respir Crit Care Med. 2014;189:1328\u201336. https:\/\/doi.org\/10.1164\/rccm.201311-2099CI.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-021-01622-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-021-01622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T07:03:23Z","timestamp":1628060603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-021-01622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1622"],"URL":"https:\/\/doi.org\/10.1186\/s12890-021-01622-3","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,4]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all enrolled subjects and their parents\/guardians in case the subject was a minor. The study was approved by the local Ethics Committee of the Antwerp University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ML, WDB and JDB are employees of Fluidda NV, a company that develops and markets the FRI technology described in this paper. The other authors have no financial relationships with any organization or company that might have an interest in the submitted work and received no direct funding from Fluidda NV.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}